Early study data on 3D-printed implants and four more updates from spine devicemakers since July 6:

OrthoPediatrics has signed an agreement with 3D-Side, a Belgian software developer that manufactures patient specific 3D cutting guides. 

Centinel Spine earned FDA approval for three more Prodisc total disc replacement devices.

Six-month data for Nexxt Spine's Matrixx 3D-printed titanium interbody implant showed strong results compared to poly-ether-ether-ketone devices.

Aurora Spine received FDA clearance for its Zip minimally invasive spine implants.

Medical technology company Implanet has seen its revenue rise in the second quarter. 

Privately held medical technology company Accelus has received a $12 million series D investment from Concord Innovation Fund II to accelerate its work on minimally invasive spinal surgery research. 

Anthem Blue Cross Blue Shield will cover ZimVie's Tether device to treat pediatric scoliosis. 

A former employee and contractor of Medtronic's Costa Rica business have been charged with conspiring to defraud the company in a $1 million scheme, according to the U.S. Department of Justice.

Zimmer Biomet has honed its position in spine and orthopedics in the first half of 2022.

A collaboration to develop implants and four more updates from spine devicemakers since June 29:

Selvon St. Clair, MD, PhD, performed the first case in Ohio using Surgalign's artificial intelligence and augmented reality system for spine surgery, Surgalign said July 6. 

Pawel Jankowski, MD, and Harvinder Bedi, MD, performed the first cases with Additive Implants' SureMAX-SA standalone cervical spacer.

Sigurd Berven, MD, has completed the first clinical use of NovApproach Spine's OneLIF interbody fusion device.

Medtronic has had a busy first half of 2022 as it has built its leadership team, strengthened its portfolio through acquisitions and made strides in its spine technology.

Fuse Medical and Oxford Performance Materials are partnering to develop spine and orthopedic implants with the OstepFab poly-ether-ketone-ketone technology.

Reliance Medical Systems, its owners and two of its physician-owned distributorships will pay a $1 million settlement to settle allegations they violated the False Claims Act by paying spine surgeons to use Reliance devices.

Scientists from ExplantLab developed an algorithm that uses patient genotype and other factors to accurately predict joint replacement surgery outcomes, Genetic Engineering and Biotechnology News reported June 27.

The first cases with 3Spine's Motus device for the lumbar spine were completed as part of an Investigational Device Exemption trial.

SeaSpine's latest commercial launch and three other updates from spine devicemakers Becker's has covered since June 22: